Revance Therapeutics
RVNC
#7444
Rank
โ‚ฌ0.30 B
Marketcap
2,96ย โ‚ฌ
Share price
0.65%
Change (1 day)
-61.93%
Change (1 year)

Revance Therapeutics (RVNC) - Net assets

Net assets on the balance sheet as of September 2024 : -โ‚ฌ0.16 Billion

According to Revance Therapeutics's latest financial reports the company has -โ‚ฌ0.16 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Revance Therapeutics - Net assets on balance sheet (from 2012 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$-โ‚ฌ0.14 Billion-1267.52%
2022-12-31$โ‚ฌ11.74 M-80.57%
2021-12-31$โ‚ฌ60.45 M-80.13%
2020-12-31$โ‚ฌ0.30 B51.18%
2019-12-31$โ‚ฌ0.20 B58.13%
2018-12-31$โ‚ฌ0.12 B-43.19%
2017-12-31$โ‚ฌ0.22 B33.1%
2016-12-31$โ‚ฌ0.16 B-27.32%
2015-12-31$โ‚ฌ0.23 B59.72%
2014-12-31$โ‚ฌ0.14 B-227.11%
2013-12-31$-โ‚ฌ0.12 Billion-30.37%
2012-12-31$-โ‚ฌ0.17 Billion36.85%
2011-12-31$-โ‚ฌ0.12 Billion

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ52.73 M-133.78%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ67.19 B-43,133.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.66 B-10,134.29%๐Ÿ‡บ๐Ÿ‡ธ USA